Old Web
English
Sign In
Acemap
>
Paper
>
The Fevipiprant Phase IIIb Systemic Corticosteroid Avoidance Study: SHIELD
The Fevipiprant Phase IIIb Systemic Corticosteroid Avoidance Study: SHIELD
2019
Klaus F. Rabe
Arnaud Bourdin
Roland Buhl
William W. Busse
J. Strigkas
C.B. Pisal
S. Hiltl
C Mailaender
Sebastian Fucile
Pablo Altman
Keywords:
Fevipiprant
Shield
Surgery
Medicine
Corticosteroid
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]